“Acquired CD20 Loss As a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma ”. 2026. Mediterranean Journal of Hematology and Infectious Diseases 18 (1): e2026014. https://doi.org/10.4084/MJHID.2026.014.